Enzo Biochem (ENZ)
0.6998 +0.0498 (+7.66%) 01/15/25 [NYSE]
0.6870 x 100 0.7500 x 4,000
Realtime by (Cboe BZX)
0.6870 x 100 0.7500 x 4,000
Realtime 0.7480 +0.0482 (-) 18:48 ET
for Wed, Jan 15th, 2025
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -26,078 | 20,288 | -18,261 | 7,875 | -28,520 |
Depreciation Amortization | 1,272 | 2,682 | 2,827 | 2,653 | 2,780 |
Accounts receivable | 2,477 | 5,033 | -1,299 | -1,110 | 1,617 |
Accounts payable and accrued liabilities | -7,737 | 1,159 | 390 | -395 | 1,214 |
Other Working Capital | -8,254 | 18,558 | -6,835 | -4,774 | 7,957 |
Other Operating Activity | 12,061 | -84,696 | 6,588 | -3,862 | -2,227 |
Operating Cash Flow | $-26,259 | $-36,976 | $-16,590 | $387 | $-17,179 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | 28,695 | -30,061 | N/A |
PPE Investments | -545 | -2,760 | -3,472 | -4,436 | -2,170 |
Other Investing Activity | 0 | 101,740 | 0 | 0 | 0 |
Investing Cash Flow | $-545 | $98,980 | $25,223 | $-34,497 | $-2,170 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | 23,846 | N/A | N/A | N/A |
Debt Issued | N/A | N/A | N/A | N/A | 7,412 |
Debt Repayment | -110 | -4,136 | -269 | -339 | -411 |
Common Stock Issued | 0 | 400 | 28 | 97 | N/A |
Other Financing Activity | -4,083 | -21,235 | 0 | 0 | 0 |
Financing Cash Flow | $-4,193 | $-1,125 | $-241 | $-242 | $7,001 |
Exchange Rate Effect | -5 | -109 | -63 | 11 | 67 |
Beginning Cash Position | 83,373 | 22,603 | 14,274 | 48,615 | 60,896 |
End Cash Position | 52,371 | 83,373 | 22,603 | 14,274 | 48,615 |
Net Cash Flow | $-31,002 | $60,770 | $8,329 | $-34,341 | $-12,281 |
Free Cash Flow | |||||
Operating Cash Flow | -26,259 | -36,976 | -16,590 | 387 | -17,179 |
Capital Expenditure | -545 | -2,760 | -3,472 | -4,436 | -2,170 |
Free Cash Flow | -26,804 | -39,736 | -20,062 | -4,049 | -19,349 |